{"id":5629,"date":"2024-06-13T16:28:39","date_gmt":"2024-06-13T16:28:39","guid":{"rendered":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/?p=5629"},"modified":"2024-06-14T01:09:05","modified_gmt":"2024-06-14T01:09:05","slug":"high","status":"publish","type":"post","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/","title":{"rendered":"Katherine High, PhD"},"content":{"rendered":"<p><img decoding=\"async\" class=\"lazyload alignnone size-full wp-image-5630\" src=\"http:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High.png\" data-orig-src=\"http:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%27300%27%20height%3D%27300%27%20viewBox%3D%270%200%20300%20300%27%3E%3Crect%20width%3D%27300%27%20height%3D%27300%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-srcset=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High-66x66.png 66w, https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High-150x150.png 150w, https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High-200x200.png 200w, https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High.png 300w\" data-sizes=\"auto\" data-orig-sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors.\u00a0A long-time member of the faculty of the Perelman School of Medicine of the University of Pennsylvania, she was also an Investigator of the Howard Hughes Medical Institute at the Children&#8217;s Hospital of Philadelphia. In 2013 she co-founded Spark Therapeutics, which she joined full-time as President and Chief Scientific Officer in 2014. At Spark she led the team that achieved the first FDA approval of a gene therapy for genetic disease, Luxturna, for a congenital form of blindness, and also led the successful Phase 1\/2 studies for Beqvez, now an approved gene therapy for hemophilia B. Spark Therapeutics was acquired by Roche in 2019. Dr. High is an elected member of the National Academy of Medicine, the Royal College of Physicians (London), and the National Academy of Sciences. Currently she is a Visiting Professor at Rockefeller University, and an Advisor to GV (formerly Google Ventures).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors.\u00a0A long-time member of the faculty of the Perelman School of Medicine of the University of<\/p>\n","protected":false},"author":6,"featured_media":5630,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[],"class_list":["post-5629","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-creative"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"mkavounis\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NINDS Genetic Strategies to Treat the Epilepsies -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies\" \/>\n\t\t<meta property=\"og:description\" content=\"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2024-06-13T16:28:39+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2024-06-14T01:09:05+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#blogposting\",\"name\":\"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies\",\"headline\":\"Katherine High, PhD\",\"author\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/wp-content\\\/uploads\\\/sites\\\/91\\\/2024\\\/06\\\/Katherine-A-High.png\",\"width\":300,\"height\":300},\"datePublished\":\"2024-06-13T16:28:39+00:00\",\"dateModified\":\"2024-06-14T01:09:05+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#webpage\"},\"articleSection\":\"Creative\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/#listItem\",\"name\":\"Creative\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/#listItem\",\"position\":2,\"name\":\"Creative\",\"item\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#listItem\",\"name\":\"Katherine High, PhD\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#listItem\",\"position\":3,\"name\":\"Katherine High, PhD\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/category\\\/creative\\\/#listItem\",\"name\":\"Creative\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#organization\",\"name\":\"Symposium for Promoting the Advancement of Research Knowledge in ME\\\/CFS (SPARKME)\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/\",\"name\":\"mkavounis\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78999b25f9750bfe24c485d98fc21efbd175a28006611d732e517a5d6e52275c?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"mkavounis\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#webpage\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/\",\"name\":\"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies\",\"description\":\"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/author\\\/mkavounis\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/wp-content\\\/uploads\\\/sites\\\/91\\\/2024\\\/06\\\/Katherine-A-High.png\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#mainImage\",\"width\":300,\"height\":300},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/2024\\\/06\\\/13\\\/high\\\/#mainImage\"},\"datePublished\":\"2024-06-13T16:28:39+00:00\",\"dateModified\":\"2024-06-14T01:09:05+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#website\",\"url\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/\",\"name\":\"Symposium for Promoting the Advancement of Research Knowledge in ME\\\/CFS (SPARKME)\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/event.roseliassociates.com\\\/ninds-genetic-strategies\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies","description":"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of","canonical_url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#blogposting","name":"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies","headline":"Katherine High, PhD","author":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author"},"publisher":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High.png","width":300,"height":300},"datePublished":"2024-06-13T16:28:39+00:00","dateModified":"2024-06-14T01:09:05+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#webpage"},"isPartOf":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#webpage"},"articleSection":"Creative"},{"@type":"BreadcrumbList","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies#listItem","position":1,"name":"Home","item":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies","nextItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/#listItem","name":"Creative"}},{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/#listItem","position":2,"name":"Creative","item":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/","nextItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#listItem","name":"Katherine High, PhD"},"previousItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#listItem","position":3,"name":"Katherine High, PhD","previousItem":{"@type":"ListItem","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/#listItem","name":"Creative"}}]},{"@type":"Organization","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#organization","name":"Symposium for Promoting the Advancement of Research Knowledge in ME\/CFS (SPARKME)","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/"},{"@type":"Person","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/","name":"mkavounis","image":{"@type":"ImageObject","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/78999b25f9750bfe24c485d98fc21efbd175a28006611d732e517a5d6e52275c?s=96&d=mm&r=g","width":96,"height":96,"caption":"mkavounis"}},{"@type":"WebPage","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#webpage","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/","name":"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies","description":"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#website"},"breadcrumb":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#breadcrumblist"},"author":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author"},"creator":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/author\/mkavounis\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-content\/uploads\/sites\/91\/2024\/06\/Katherine-A-High.png","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#mainImage","width":300,"height":300},"primaryImageOfPage":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/#mainImage"},"datePublished":"2024-06-13T16:28:39+00:00","dateModified":"2024-06-14T01:09:05+00:00"},{"@type":"WebSite","@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#website","url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/","name":"Symposium for Promoting the Advancement of Research Knowledge in ME\/CFS (SPARKME)","inLanguage":"en-US","publisher":{"@id":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/#organization"}}]},"og:locale":"en_US","og:site_name":"NINDS Genetic Strategies to Treat the Epilepsies -","og:type":"article","og:title":"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies","og:description":"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of","og:url":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/","article:published_time":"2024-06-13T16:28:39+00:00","article:modified_time":"2024-06-14T01:09:05+00:00","twitter:card":"summary_large_image","twitter:title":"Katherine High, PhD - NINDS Genetic Strategies to Treat the Epilepsies","twitter:description":"Dr. Katherine High trained in internal medicine, hematology, and molecular genetics. Her pioneering bench-to-bedside studies of gene therapy for hemophilia led to a series of basic and clinical investigations that characterized the human immune response to AAV gene delivery vectors. A long-time member of the faculty of the Perelman School of Medicine of the University of"},"aioseo_meta_data":{"post_id":"5629","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2024-06-13 16:28:39","updated":"2025-07-23 20:34:15","focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/\" title=\"Creative\">Creative<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tKatherine High, PhD\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies"},{"label":"Creative","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/category\/creative\/"},{"label":"Katherine High, PhD","link":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/2024\/06\/13\/high\/"}],"_links":{"self":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts\/5629","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/comments?post=5629"}],"version-history":[{"count":1,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts\/5629\/revisions"}],"predecessor-version":[{"id":5631,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/posts\/5629\/revisions\/5631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/media\/5630"}],"wp:attachment":[{"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/media?parent=5629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/categories?post=5629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/event.roseliassociates.com\/ninds-genetic-strategies\/wp-json\/wp\/v2\/tags?post=5629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}